These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Genetic testing in multiple endocrine neoplasia and related syndromes. Calender A. Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051 [Abstract] [Full Text] [Related]
7. Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. Zimering MB, Brandi ML, deGrange DA, Marx SJ, Streeten E, Katsumata N, Murphy PR, Sato Y, Friesen HG, Aurbach GD. J Clin Endocrinol Metab; 1990 Jan; 70(1):149-54. PubMed ID: 1967177 [Abstract] [Full Text] [Related]
8. [Diagnosis, therapy and screening of multiple endocrine neoplasia type I (MEN I) in four endocrinologic centers]. Schaaf L, Nies G, Raue F, Tuschy U, Seif FJ, Trojan J, Usadel KU. Med Klin (Munich); 1994 Jan 15; 89(1):1-6. PubMed ID: 7908402 [Abstract] [Full Text] [Related]
9. Localization and identification of the multiple endocrine neoplasia type 1 disease gene. Larsson C, Friedman E. Endocrinol Metab Clin North Am; 1994 Mar 15; 23(1):67-79. PubMed ID: 7913030 [Abstract] [Full Text] [Related]
10. Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism. Perrier ND, Villablanca A, Larsson C, Wong M, Ituarte P, Teh BT, Clark OH. World J Surg; 2002 Aug 15; 26(8):907-13. PubMed ID: 12016470 [Abstract] [Full Text] [Related]
11. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]. Pomares Gómez FJ, Bernabé Espinosa MJ, Matías-Guiu Guía X, Rodríguez González JM, Soriano Palao J, Sola Pérez J, Carbonell Meseguer P, Parrilla Paricio P, Tébar Massó FJ. Med Clin (Barc); 1999 May 15; 112(17):646-50. PubMed ID: 10374185 [Abstract] [Full Text] [Related]
12. Application of linked DNA markers to screening families with multiple endocrine neoplasia type 2A. Telenius H, Mathew CG, Nakamura Y, Easton DF, Clark J, Neumann HP, Ziegler WH, Schinzel A, Ponder BA. Eur J Surg Oncol; 1990 Apr 15; 16(2):134-40. PubMed ID: 1969807 [Abstract] [Full Text] [Related]
16. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Machens A, Schaaf L, Karges W, Frank-Raue K, Bartsch DK, Rothmund M, Schneyer U, Goretzki P, Raue F, Dralle H. Clin Endocrinol (Oxf); 2007 Oct 15; 67(4):613-22. PubMed ID: 17590169 [Abstract] [Full Text] [Related]
17. Hereditary medullary thyroid carcinoma. Vasen HF, Vermey A. Cancer Detect Prev; 1995 Oct 15; 19(2):143-50. PubMed ID: 7750101 [Abstract] [Full Text] [Related]
18. [Clinical genetics of neuroendocrine tumors]. Karges W, Adler G. Med Klin (Munich); 2003 Dec 15; 98(12):712-6. PubMed ID: 14685672 [Abstract] [Full Text] [Related]
19. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus. Fassbender WJ, Krohn-Grimberghe B, Görtz B, Litzlbauer D, Stracke H, Raue F, Kaiser HE. Anticancer Res; 2000 Dec 15; 20(6C):4877-87. PubMed ID: 11205236 [Abstract] [Full Text] [Related]
20. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1. Balogh K, Hunyady L, Patocs A, Gergics P, Valkusz Z, Toth M, Racz K. Clin Endocrinol (Oxf); 2007 Nov 15; 67(5):727-34. PubMed ID: 17953629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]